>There is a significant risk that Novavax will go bankrupt due to the large amount of money it is burning through. However, there is also a chance that the company will come out with an innovative vaccine that could send its stock soaring. At $9 per share, Novavax appears to be a risky gamble but one that could pay off handsomely if things go well.